1 Definition and classification

Hyperkalemia is an elevation of the potassium concentration in the blood above the normal range. Because potassium is crucial for nerve conduction, muscle contraction, and cardiac electrical stability, even moderate increases can have important physiologic effects. The condition is often identified during laboratory testing, but in more severe forms it may produce weakness, conduction abnormalities, or dangerous arrhythmias.

Classification is generally based on serum potassium level, though the clinical context matters as much as the number itself. A rapid rise can be more hazardous than a stable chronic elevation at a similar value, especially when kidney function is impaired or other electrolytes are abnormal.

1.1 Normal potassium physiology

Potassium is primarily an intracellular ion, with only a small fraction present in the extracellular fluid. This distribution is maintained by the sodium-potassium pump, renal excretion, and hormonal regulation, particularly by aldosterone. The kidneys are the main route of potassium elimination, while the intestines contribute a smaller share.

1.2 Diagnostic thresholds

Diagnostic thresholds vary slightly among laboratories, but hyperkalemia is commonly defined as a serum potassium level above about 5.0 to 5.5 mmol/L. Interpretation should consider specimen handling, patient condition, and whether the elevation is confirmed on repeat testing.

1.2.1 Mild hyperkalemia

Mild hyperkalemia usually refers to a small increase above the upper limit of normal. It may produce no symptoms and is often found incidentally, though it can still signal impaired potassium handling.

1.2.2 Moderate hyperkalemia

Moderate hyperkalemia represents a more substantial elevation and carries a greater risk of electrocardiographic changes and muscle symptoms. Treatment urgency depends on the presence of symptoms, the ECG, and the trend in potassium level.

1.2.3 Severe hyperkalemia

Severe hyperkalemia is typically associated with marked potassium elevation and a significant risk of life-threatening cardiac complications. It is treated as a medical emergency, especially when ECG abnormalities or neuromuscular symptoms are present.

1.3 Acute and chronic presentations

Acute hyperkalemia develops over hours or days and may produce abrupt symptoms or conduction changes. Chronic hyperkalemia evolves more gradually, and patients may appear relatively well despite elevated potassium, particularly when the body has partially adapted. Nonetheless, chronic elevation remains clinically important because sudden worsening can occur.

2 Causes

Hyperkalemia usually reflects either reduced potassium excretion, movement of potassium out of cells, increased intake under special circumstances, or a combination of these factors. In practice, kidney disease and medications are among the most common contributors. Often more than one cause is present at the same time.

2.1 Decreased renal excretion

Impaired kidney elimination is the most frequent mechanism. When the kidneys cannot adequately excrete potassium, even ordinary intake may lead to accumulation.

2.1.1 Acute kidney injury

Acute kidney injury can cause a rapid decline in potassium excretion. The risk is especially high when urine output falls substantially or when tissue breakdown adds extra potassium to the circulation.

2.1.2 Chronic kidney disease

Chronic kidney disease reduces the kidney’s ability to maintain potassium balance. Patients may remain stable for long periods, but dietary changes, dehydration, medications, or intercurrent illness can precipitate hyperkalemia.

2.1.3 Hypoaldosteronism and adrenal disorders

Low aldosterone activity decreases distal tubular potassium secretion. This may occur in adrenal insufficiency or in conditions that reduce aldosterone production or action, leading to persistent potassium retention.

2.2 Medications

A wide range of drugs can elevate potassium by reducing renal excretion or altering hormonal pathways. Medication-related hyperkalemia is common in patients with kidney disease, diabetes, or advanced age.

2.2.1 Potassium-sparing diuretics

Potassium-sparing diuretics reduce urinary potassium loss and can raise serum levels, especially when combined with other agents that impair excretion. Their effect is often predictable but may become clinically important in susceptible patients.

2.2.2 Renin-angiotensin system inhibitors

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and related agents can lower aldosterone activity and promote potassium retention. These drugs are frequently beneficial for cardiovascular and kidney disease but require monitoring.

Other medications may contribute, including certain nonsteroidal anti-inflammatory drugs, heparin, some antibiotics, and drugs that interfere with cellular uptake or renal handling of potassium. The risk is increased when several such agents are used together.

2.3 Redistribution of potassium

Potassium may shift from the intracellular compartment into the bloodstream without a major change in total body potassium. This mechanism can produce relatively rapid hyperkalemia.

2.3.1 Metabolic acidosis

Acidosis can drive potassium out of cells as hydrogen ions move inward to help buffer the pH disturbance. The effect is more pronounced in some types of acidosis than others.

2.3.2 Insulin deficiency

Insulin promotes movement of potassium into cells. When insulin is deficient, as in uncontrolled diabetes, potassium may rise in the extracellular fluid even if total body potassium is depleted.

2.3.3 Tissue breakdown

Cell destruction releases intracellular potassium into the blood. Causes include rhabdomyolysis, hemolysis, burns, and tumor lysis, all of which can generate substantial potassium loads.

2.4 Excess potassium intake

Dietary or supplemental potassium alone rarely causes hyperkalemia in people with normal kidney function, but it can be important when excretion is impaired or when intake is unusually concentrated.

2.4.1 Dietary sources

Potassium-rich foods and salt substitutes may contribute, particularly in patients with kidney disease who are advised to limit intake. The total burden depends on both amount consumed and renal capacity.

Potassium tablets, powders, and intravenous preparations can cause hyperkalemia if taken in excess or administered too rapidly. Supplement use is a common overlooked contributor in clinical practice.

3 Pathophysiology

The effects of hyperkalemia arise from altered potassium gradients across cell membranes. These changes influence resting membrane potential, excitability, and conduction, especially in excitable tissues such as muscle and myocardium.

3.1 Potassium homeostasis

Potassium balance depends on intake, internal distribution, and renal excretion. Hormones such as insulin and aldosterone help keep extracellular potassium within a narrow range despite frequent dietary fluctuations.

3.2 Renal handling of potassium

The distal nephron plays the major role in potassium secretion. Sodium delivery, tubular flow, aldosterone activity, and acid-base status all affect how much potassium is excreted.

3.3 Cellular shifts and membrane excitability

As extracellular potassium rises, the resting membrane potential becomes less negative. This initially increases excitability but eventually impairs normal depolarization and conduction, which can produce weakness and conduction defects.

3.4 Cardiac electrophysiologic effects

The heart is particularly sensitive to potassium changes. Hyperkalemia slows conduction, alters repolarization, and can progress from subtle ECG changes to severe bradyarrhythmias, ventricular arrhythmias, or asystole.

4 Clinical features

Clinical presentation ranges from completely silent laboratory abnormality to severe neuromuscular and cardiac manifestations. Symptoms often reflect both the potassium level and the speed at which it rose.

4.1 Neuromuscular symptoms

Skeletal muscle is affected by changes in membrane excitability. Symptoms may be mild and nonspecific at first, then intensify as potassium rises.

4.1.1 Weakness

Weakness is a common manifestation and may involve the limbs, trunk, or respiratory muscles in severe cases. It is often described as heaviness or reduced power rather than pain.

4.1.2 Paresthesia

Some patients experience tingling, numbness, or abnormal sensations. These symptoms are not specific to hyperkalemia but may accompany other neuromuscular complaints.

4.1.3 Paralysis

Marked hyperkalemia can cause flaccid paralysis. Respiratory muscle involvement is uncommon but medically urgent.

4.2 Cardiac symptoms

Cardiac manifestations may occur with or without prior neuromuscular complaints. Because the consequences can be sudden, cardiac symptoms warrant immediate attention.

4.2.1 Palpitations

Patients may notice an awareness of the heartbeat or an irregular pulse. Palpitations are nonspecific but may accompany conduction disturbances.

4.2.2 Bradycardia

Slow heart rate is a concerning feature of significant hyperkalemia. It may progress despite apparent clinical stability.

4.2.3 Arrhythmias

Hyperkalemia can produce a broad spectrum of arrhythmias, including conduction block and malignant ventricular rhythms. The risk increases as potassium rises and when other cardiac disease is present.

4.3 Asymptomatic cases

Many cases are asymptomatic and discovered incidentally on routine testing. This is particularly common in chronic kidney disease, where adaptation and gradual onset may blunt symptoms.

5 Diagnosis

Diagnosis relies on confirmation of elevated serum potassium, assessment of urgency, and identification of the cause. Because laboratory artifact can mimic the condition, verification is often important when the clinical picture is unclear.

5.1 History and physical examination

History should assess kidney disease, diabetes, medication use, dietary supplements, recent illness, and symptoms of weakness or palpitations. Physical examination may reveal bradycardia, neuromuscular weakness, or signs of dehydration or kidney dysfunction.

5.2 Laboratory evaluation

Laboratory studies help confirm the diagnosis, assess severity, and identify contributing disorders such as kidney failure or acid-base imbalance.

5.2.1 Serum potassium measurement

Serum potassium measurement is the central test. Repeat sampling may be needed if the result is unexpected or if pseudohyperkalemia is suspected.

5.2.2 Renal function tests

Creatinine, blood urea nitrogen, and urine output assessment help determine whether impaired excretion is contributing. These results also guide treatment selection.

5.2.3 Acid-base assessment

Serum bicarbonate and blood gas analysis can identify acidosis or other disturbances that influence potassium distribution. This information may affect both diagnosis and management.

5.3 Electrocardiography

ECG evaluation is essential when hyperkalemia is suspected, particularly in moderate or severe cases. Findings may be present even when symptoms are limited.

5.3.1 ECG changes by severity

Early ECG changes can include peaked T waves and shortened repolarization intervals. More advanced hyperkalemia may cause loss of P waves, widening of the QRS complex, conduction block, and a sine-wave pattern before arrest.

5.4 Differential diagnosis

Other conditions can resemble hyperkalemia or coexist with it. Distinguishing true potassium elevation from laboratory artifact is a key step.

5.4.1 Pseudohyperkalemia

Pseudohyperkalemia is an artificially high potassium result caused by sample hemolysis, prolonged tourniquet use, thrombocytosis, leukocytosis, or specimen handling problems. Clinical correlation and repeat testing help confirm the diagnosis.

5.4.2 Other electrolyte disturbances

Hypocalcemia, hypomagnesemia, and sodium abnormalities may influence neuromuscular or cardiac symptoms. They do not usually cause hyperkalemia directly but can affect presentation and risk.

6 Management

Management depends on severity, ECG findings, symptoms, and underlying cause. The main goals are to stabilize the myocardium, shift potassium into cells when needed, and remove excess potassium from the body.

6.1 Initial stabilization

Immediate assessment determines whether urgent intervention is required. Patients with severe elevation, ECG changes, or symptoms are treated promptly.

6.1.1 Cardiac monitoring

Continuous cardiac monitoring is recommended in significant cases because rhythm changes may develop suddenly. Serial ECGs may be necessary during treatment.

6.1.2 Indications for urgent treatment

Urgent therapy is indicated when hyperkalemia is severe, rapidly rising, associated with ECG abnormalities, or accompanied by marked weakness or arrhythmia. Clinical judgment is especially important when lab values and symptoms do not match.

6.2 Membrane stabilization

When the heart is at risk, the first priority is to protect cardiac conduction. This does not lower potassium directly but reduces immediate danger.

6.2.1 Intravenous calcium

Intravenous calcium stabilizes the cardiac membrane and can rapidly improve ECG abnormalities. Its effect is temporary, so additional therapies are usually required.

6.3 Potassium shifting therapies

These measures lower extracellular potassium by moving it into cells. They act relatively quickly but do not remove potassium from the body.

6.3.1 Insulin and glucose

Insulin drives potassium into cells, and glucose is given to reduce the risk of hypoglycemia. This combination is one of the most effective rapid therapies.

6.3.2 Beta-agonists

Inhaled beta-agonists can promote intracellular potassium uptake. Their effect may be additive with insulin, though response varies among patients.

6.3.3 Sodium bicarbonate

Sodium bicarbonate may be useful when metabolic acidosis is present. Its potassium-lowering effect is less reliable than insulin or beta-agonists, but it can help in selected cases.

6.4 Potassium removal

Definitive treatment requires elimination of excess potassium from the body. The choice depends on kidney function, volume status, and severity.

6.4.1 Diuretics

Loop diuretics can increase urinary potassium excretion in patients with adequate kidney function and urine output. They are often used with volume management.

6.4.2 Potassium binders

Potassium-binding agents reduce gastrointestinal potassium absorption and promote fecal elimination. They are more useful for persistent or recurrent hyperkalemia than for immediate life-threatening episodes.

6.4.3 Dialysis

Dialysis is the most effective method for rapid potassium removal, especially in severe hyperkalemia or when kidney failure limits other treatments. It is often used when medical therapy is insufficient or when recurrence is likely.

6.5 Treatment of underlying cause

Correcting the precipitating problem is essential to prevent recurrence. This may include stopping offending drugs, treating kidney injury, addressing acidosis, or managing endocrine disorders.

6.6 Follow-up and monitoring

Repeat potassium measurements are needed after treatment to confirm improvement and detect rebound hyperkalemia. Ongoing monitoring is particularly important in patients with chronic kidney disease or persistent risk factors.

7 Complications

Complications arise from both the electrolyte disturbance itself and the interventions used to treat it. Prompt management reduces but does not eliminate risk.

7.1 Cardiac arrhythmias

The most important complication is disturbance of cardiac rhythm. Conduction abnormalities may progress quickly and unpredictably.

7.2 Cardiac arrest

Untreated severe hyperkalemia can lead to ventricular standstill or asystole. This is the major life-threatening consequence of the disorder.

7.3 Recurrent hyperkalemia

Recurrence is common when the underlying cause is not corrected or when kidney function remains impaired. Rebound after initial treatment can also occur.

Therapy can produce adverse effects such as hypoglycemia after insulin, hypercalcemia from calcium administration, fluid overload, or electrolyte shifts from dialysis. Monitoring helps reduce these risks.

8 Prognosis

Outcome depends on potassium level, speed of onset, cardiac involvement, and overall health status. Many patients recover fully when the cause is identified and treated promptly.

8.1 Severity and rate of rise

A rapid increase in potassium is more dangerous than a gradual rise. Severe elevations carry the greatest risk of arrhythmia and death.

8.2 Role of comorbid disease

Kidney disease, heart disease, diabetes, and concurrent acid-base abnormalities worsen prognosis. Patients with multiple contributing factors are more likely to experience recurrent episodes.

8.3 Impact of timely intervention

Early recognition and treatment markedly improve outcome. Rapid correction of dangerous potassium levels can prevent irreversible cardiac events.

9 Prevention

Prevention focuses on identifying at-risk individuals, limiting avoidable potassium increases, and monitoring closely when risk changes.

9.1 Monitoring in high-risk patients

Patients with chronic kidney disease, diabetes, or a history of hyperkalemia should have periodic potassium checks. Monitoring is also important after medication changes or acute illness.

9.2 Medication review

Regular review of prescriptions, over-the-counter products, and supplements can reveal contributors to rising potassium. Dose adjustment or substitution may reduce risk.

9.3 Dietary counseling

Dietary guidance may help patients limit excessive potassium intake when needed. Advice should be individualized, since overly restrictive diets are not appropriate for everyone.

9.4 Chronic kidney disease management

Good management of chronic kidney disease supports stable potassium control. This includes attention to volume status, blood pressure, metabolic acidosis, and adherence to follow-up testing.